Stifel Financial’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-21,972
| Closed | -$288K | – | 3386 |
|
|
2024
Q3 | $288K | Sell |
21,972
-1,452
| -6% | -$19K | ﹤0.01% | 2983 |
|
|
2024
Q2 | $329K | Sell |
23,424
-1,452
| -6% | -$20.4K | ﹤0.01% | 2866 |
|
|
2024
Q1 | $420K | Buy |
+24,876
| New | +$420K | ﹤0.01% | 2720 |
|
|
2017
Q4 | – | Sell |
-64,500
| Closed | -$677K | – | 2655 |
|
|
2017
Q3 | $677K | Buy |
64,500
+4,000
| +7% | +$42K | ﹤0.01% | 1711 |
|
|
2017
Q2 | $667K | Buy |
60,500
+2,500
| +4% | +$27.6K | ﹤0.01% | 1711 |
|
|
2017
Q1 | $561K | Hold |
58,000
| – | – | ﹤0.01% | 1753 |
|
|
2016
Q4 | $603K | Buy |
58,000
+2,000
| +4% | +$20.8K | ﹤0.01% | 1677 |
|
|
2016
Q3 | $694K | Buy |
56,000
+7,000
| +14% | +$86.8K | ﹤0.01% | 1527 |
|
|
2016
Q2 | $1.19M | Buy |
49,000
+5,000
| +11% | +$121K | 0.01% | 1245 |
|
|
2016
Q1 | $486K | Buy |
44,000
+10,750
| +32% | +$119K | ﹤0.01% | 1595 |
|
|
2015
Q4 | $406K | Hold |
33,250
| – | – | ﹤0.01% | 1772 |
|
|
2015
Q3 | $542K | Buy |
33,250
+3,000
| +10% | +$48.9K | ﹤0.01% | 1505 |
|
|
2015
Q2 | $641K | Buy |
30,250
+4,250
| +16% | +$90.1K | ﹤0.01% | 1558 |
|
|
2015
Q1 | $467K | Sell |
26,000
-2,980
| -10% | -$53.5K | ﹤0.01% | 1659 |
|
|
2014
Q4 | $496K | Buy |
28,980
+2,895
| +11% | +$49.5K | ﹤0.01% | 1614 |
|
|
2014
Q3 | $373K | Buy |
26,085
+85
| +0.3% | +$1.22K | ﹤0.01% | 1684 |
|
|
2014
Q2 | $390K | Buy |
26,000
+10,000
| +63% | +$150K | ﹤0.01% | 1633 |
|
|
2014
Q1 | $214K | Buy |
+16,000
| New | +$214K | ﹤0.01% | 1885 |
|